tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC

Compare Cartesian Therapeutics (RNAC) vs. Competitors

1,150 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Cartesian Therapeutics
$6.39
$169.39M
-1.44
-48.84%
5 Buy
1 Hold
0 Sell
Strong Buy
Puma Biotechnology
$6.76
$343.93M
9.56
130.72%
0 Buy
1 Hold
0 Sell
Hold
DBV Technologies SA - American
$20.50
$1.21B
-3.63
217.34%
5 Buy
0 Hold
0 Sell
Strong Buy
Voyager Therapeutics
$3.99
$237.80M
-1.93
18.40%
8 Buy
0 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$5.65
$450.15M
-1.84
98.25%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$17.39
$849.46M
-0.19
40.24%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RNAC
Cartesian Therapeutics
6.39
-5.95
-48.22%
PBYI
Puma Biotechnology
6.76
3.84
131.51%
DBVT
DBV Technologies SA - American
20.50
12.64
160.81%
VYGR
Voyager Therapeutics
3.99
0.88
28.30%
AVIR
Atea Pharmaceuticals
5.65
2.75
94.83%
VOR
Vor Biopharma
17.39
5.59
47.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts